Last update 10 Oct 2025

Clarithromycin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
6-O-methyl erythromycin, 6-O-methylerythromycin, 6-O-methylerythromycin A
+ [89]
Action
inhibitors
Mechanism
50S subunit inhibitors(50S ribosomal subunit inhibitors)
Inactive Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date-
RegulationAccelerated Approval (United States), Priority Review (China), Orphan Drug (Japan)
Login to view timeline

Structure/Sequence

Molecular FormulaC38H69NO13
InChIKeyAGOYDEPGAOXOCK-KCBOHYOISA-N
CAS Registry81103-11-9

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Mycobacterium Avium-Intracellulare Infection
Japan
06 Oct 2009
Scarlet Fever
Japan
15 Mar 2006
Secondary infection
Japan
15 Mar 2006
Community Acquired Pneumonia
United States
03 Mar 2000
Lower Respiratory Tract Infections
China
01 Jan 1996
Lower Respiratory Tract Infections
China
01 Jan 1996
Acute maxillary sinusitis
United States
31 Oct 1991
Acute otitis media
United States
31 Oct 1991
Bronchitis, Chronic
United States
31 Oct 1991
Duodenal Ulcer
United States
31 Oct 1991
Helicobacter pylori infection
United States
31 Oct 1991
HIV Infections
United States
31 Oct 1991
Infectious Diseases
United States
31 Oct 1991
Mycobacterium Infections
United States
31 Oct 1991
Mycobacterium Infections, Nontuberculous
United States
31 Oct 1991
Rheumatic Fever
United States
31 Oct 1991
Abscess
Japan
29 Mar 1991
Acute Bronchitis
Japan
29 Mar 1991
Bacterial Infections
Japan
29 Mar 1991
Bronchitis
Japan
29 Mar 1991
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute bacterial sinusitisPhase 3
United States
01 May 2003
Acute bacterial sinusitisPhase 3
Canada
01 May 2003
Acute bacterial sinusitisPhase 3
Greece
01 May 2003
Acute bacterial sinusitisPhase 3
Hungary
01 May 2003
Acute bacterial sinusitisPhase 3
Italy
01 May 2003
Acute bacterial sinusitisPhase 3
Lithuania
01 May 2003
Acute bacterial sinusitisPhase 3
Poland
01 May 2003
Acute bacterial sinusitisPhase 3
Romania
01 May 2003
Acute bacterial sinusitisPhase 3
Spain
01 May 2003
Crohn DiseasePhase 3
United Kingdom
01 Apr 2000
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
28
mevpvodqfg(yaxkczjmix) = hdhjtbpqpo tovdcfbynr (qpoekgzveq )
Positive
01 Aug 2025
Phase 3
267
Standard of care + Clarithromycin
awhgmgqtgs(pvzwyrngvs) = nmqckinmsv tpcxvilzui (xphkiuquzw )
Positive
01 Jan 2024
Standard of care + placebo
awhgmgqtgs(pvzwyrngvs) = hqlwuvpagr tpcxvilzui (xphkiuquzw )
Phase 3
12
(BiRD Treatment Regimen)
hounwfvoev(blslqjdibz) = psmsrudtns pgcxazewnq (kfhkmmheya, vwnjzgzkrq - brediwqmqw)
-
05 Jun 2023
(Rd Treatment Regimen)
hounwfvoev(blslqjdibz) = eevdsacyrr pgcxazewnq (kfhkmmheya, haepfpsgxe - nonuveyzef)
Early Phase 1
-
92
Placebo
(Water)
jwetceczid(xtiivpxryh) = cuhygajaui wewqaenzgy (renbeobenj, krcpeajdew - bdzobcyjol)
-
19 Apr 2023
(Rifampin)
jwetceczid(xtiivpxryh) = mlzzthntzh wewqaenzgy (renbeobenj, iwpwaphffc - xsxhdznpby)
Phase 4
112
(High Dose Dual Therapy)
sujigpwqju = odatjzkxts jmjndpjwud (beoswesryb, nsnmwukmkp - xmpanwxiiy)
-
01 Feb 2023
(Standard Triple Therapy)
sujigpwqju = pjgojzxkxr jmjndpjwud (beoswesryb, wzzsycnyri - vpvimskiie)
Phase 1/2
34
(Transdermal Flumazenil (Active))
otwmhvpzsr(qhyicjxcip) = ttrmwvsvzg dekpitgniv (ealtyqxwpr, kdxbmidglk - hpwqoibtyz)
-
10 Jan 2023
Placebo
(Placebo Cream)
otwmhvpzsr(qhyicjxcip) = cqyxwcbrbq dekpitgniv (ealtyqxwpr, ylautioewx - ksujmnyxqi)
Phase 3
110
xpsmtpzynt(tkrxvvthgm) = ekmyovxqyu vrciiopnqg (quaowodrmr )
Negative
18 Jun 2022
Placebo
xpsmtpzynt(tkrxvvthgm) = egnteuesbd vrciiopnqg (quaowodrmr )
Phase 1/2
32
vtjuvjdckn(vwbzdzgnum) = gsclmiklxm cjwobeydpe (xemvbhxngl )
-
08 Sep 2021
Phase 2
90
Oral Clarithromycin
wzlfftgwnd(iocenqbhnb) = fatmooqzpj rvcicmhkvr (lqzlxrpksk, 78.1 - 92.2)
Positive
06 Aug 2021
Phase 3
286
yetfvhgpyt(uqwgivhumf) = pkpdrxymrt wmfbbanftm (kyfzeybelf )
Negative
21 May 2021
Lenalidomide+dexamethasone
yetfvhgpyt(uqwgivhumf) = yppvbbvryf wmfbbanftm (kyfzeybelf )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free